Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Market watchers are predicting strong results driven by the robust sales of Lilly's blockbuster medications, particularly its insulin portfolio. However, there are also concerns about potential headwinds from ris